Pascal and Francis Bibliographic Databases

Help

Search results

Your search

kw.\*:("METHOTREXATE")

Filter

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Language

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Origin

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 6811

  • Page / 273
Export

Selection :

  • and

METHOTREXATE ANALOGUES. XI. UNAMBIGUOUS CHEMICAL SYNTHESIS AND IN VITRO BIOLOGICAL EVALUATION OF ALPHA - AND GAMMA -MONOESTERS AS POTENTIAL PRODRUGS.ROSOWSKY A; BEARDSLEY GP; ENSMINGER WD et al.1978; J. MEDICIN. CHEM.; U.S.A.; DA. 1978; VOL. 21; NO 4; PP. 380-386; BIBL. 25 REF.Article

ACCUMULATION OF METHOTREXATE DIGLUTAMATE IN HUMAN LIVER DURING METHROTREXATE THERAPY.JACOBS SA; DERR CJ; JOHNS DG et al.1977; BIOCHEM. PHARMACOL.; G.B.; DA. 1977; VOL. 26; NO 23; PP. 2310-2313; BIBL. 18 REF.Article

EFFECTS OF METHOTREXATE ESTERS ON NORMAL AND PSORIATIC SKIN.WEINSTEIN GD; MCCULLOUGH JL.1975; ARCH. DERMATOL.; U.S.A.; DA. 1975; VOL. 111; NO 4; PP. 471-475; BIBL. 23 REF.Article

Toward a better understanding of methotrexateKREMER, Joel M.Arthritis and rheumatism. 2004, Vol 50, Num 5, pp 1370-1382, issn 0004-3591, 13 p.Article

Optimal administration and dosage of methotrexateBRAUN, J.Clinical and experimental rheumatology (Testo stampato). 2010, Vol 28, Num 5, issn 0392-856X, S46-S51, SUP61Article

Metabolism of the diaminoantifolates: biosynthesis and pharmacology of the 7-hydroxyl and polyglutamyl metabolites of methotrexate and related antifolatesMATHERLY, L. H; SEITHER, R. L; GOLDMAN, I. D et al.Pharmacology & therapeutics (Oxford). 1987, Vol 35, Num 1-2, pp 27-56, issn 0163-7258Article

Initiative 3 E: Evidence, Expertise, ExchangeWENDLING, Daniel.Rhumatos. 2010, Vol 7, Num 58, pp 5-6, issn 1771-0081, 2 p., CAH3Article

Use of methotrexate in patients with psoriasisKUHN, A; RULAND, V; PATSINAKIDIS, N et al.Clinical and experimental rheumatology (Testo stampato). 2010, Vol 28, Num 5, issn 0392-856X, S138-S144, SUP61Article

Approaching an individual methotrexate regimen in leptomeningeal carcinomatosisHUBER, Matthias; NOLTING, Mirjam; BAUER, Steffen et al.Journal of the neurological sciences. 2005, Vol 236, Num 1-2, pp 37-41, issn 0022-510X, 5 p.Article

The sequelae of cranial irradiation on human cognitionSARKISSIAN, Vahé.Neuroscience letters. 2005, Vol 382, Num 1-2, pp 118-123, issn 0304-3940, 6 p.Article

Use of methotrexate in young patients with respect to the reproductive systemGROMNICA-IHLE, E; KRÜGER, K.Clinical and experimental rheumatology (Testo stampato). 2010, Vol 28, Num 5, issn 0392-856X, S80-S84, SUP61Article

PLASMA LEVELS OF 7-HYDROXYMETHOTREXATE AFTER HIGH-DOSE METHOTREXATE TREATMENTMILANO G; THYSS A; SCHNEIDER M et al.1983; CANCER CHEMOTHERAPY AND PHARMACOLOGY; ISSN 0344-5704; DEU; DA. 1983; VOL. 11; NO 1; PP. 29-32; BIBL. 14 REF.Article

A COMPARISON OF THE BIOLOGICAL EFFECTS OF DICHLOROMETHOTREXATE AND METHOTREXATE ON HUMAN LEUKEMIC CELLS IN CULTURETAKAHASHI I; OHNUMA T; HOLLAND JF et al.1979; CANCER RES.; USA; DA. 1979; VOL. 39; NO 4; PP. 1264-1268; BIBL. 32 REF.Article

METHOTREXATE AND 7-HYDROXYMETHOTREXATE: SERUM LEVEL MONITORING BY HIGH-PERFORMANCE LIQUID CHROMATOGRAPHYCANFELL C; SADEE W.1980; CANCER TREATM. REP.; USA; DA. 1980; VOL. 64; NO 1; PP. 165-169; BIBL. 9 REF.Article

HIGH-PRESSURE LIQUID CHROMATOGRAPHIC DETERMINATION OF METHOTREXATE AND ITS MAJOR METABOLITE, 7-HYDROXYMETHOTREXATE, IN HUMAN PLASMA.WATSON E; COHEN JL; CHAN KK et al.1978; CANCER TREATM. REP.; U.S.A.; DA. 1978; VOL. 62; NO 3; PP. 381-387; BIBL. 25 REF.Article

Mesial Temporal Sclerosis Associated With Methotrexate-Induced LeukoencephalopathyHAMAMOTO, Kouhei; ORIUCHI, Noboru; KANAZAWA, Takashi et al.Pediatric neurology. 2009, Vol 40, Num 4, pp 306-309, issn 0887-8994, 4 p.Article

EEN PATIENT MET DE ZIEKTE VAN REITER; POSITIVE ERVARINGEN MET METHOTREXAATTHERAPIE. = UN SUJET ATTEINT DE LA MALADIE DE REITER; EXPERIMENTATION POSITIVE DU TRAITEMENT PAR LE METHOTREXATEHAAS FDB.1976; NEDERL. T. GENEESKDE; NEDERL.; DA. 1976; VOL. 120; NO 14; PP. 611-614; ABS. ANGL.; BIBL. 29 REF.Article

EFFECTS OF METHOTREXATE ON INTRAPERIPLASMIC AND AXENIC GROWTH OF BDELLOVIBRIO BACTERIOVORUSPRITCHARD MA; LANGLEY D; RITTENBERG SC et al.1975; J. BACTERIOL.; U.S.A.; DA. 1975; VOL. 121; NO 3; PP. 1131-1136; BIBL. 31REF.Article

CHEMIOTERAPIA DEL GESTOCORIONEPITELIOMA. = CHIMOTHERAPIE DU CHORIOEPITHELIOMEGASPARI F; BUZZONI P; MAZZEI T et al.1975; TUMORI; ITAL.; DA. 1975; VOL. 61; NO 5; PP. 433-439; ABS. ANGL.; BIBL. 1 P.Article

A RAPID AND SPECIFIC RADIOIMMUNOASSAY FOR METHOTREXATERASO V; SCHREIBER R.1975; CANCER RES.; U.S.A.; DA. 1975; VOL. 35; NO 6; PP. 1407-1410; BIBL. 12REF.Article

ASSAY FOR CITROVORUM FACTOR (NSC-3590) IN THE PRESENCE OF METHOTREXATE (NSC-740)MEHTA BM; HUTCHISON DJ.1975; CANCER CHEMOTHERAPY REP. 1; U.S.A.; DA. 1975; VOL. 59; NO 5; PP. 935-937; BIBL. 16 REF.Article

NEUROTOXICITY OF COMMONLY USED ANTINEOPLASTIC AGENTS (FIRST OF TWO PARTS)WEISS HD; WALKER MD; WIERNIK PH et al.1974; NEW ENGL. J. MED.; U.S.A.; DA. 1974; VOL. 291; NO 2; PP. 75-81; BIBL. 1P.1/2Article

ADJUVANT METHOTREXATE AND CITROVORUM-FACTOR TREATMENT OF OSTEOGENIC SARCOMAJAFFE N; FREI E III; TRAGGIS D et al.1974; NEW ENGL. J. MED.; U.S.A.; DA. 1974; VOL. 291; NO 19; PP. 994-997; BIBL. 25REF.Article

RESULTATS DU TRAITEMENT DES TUMEURS SOLIDES PAR L'ASSOCIATION METHOTREXATE A DOSES MASSIVES ET ACIDE FOLINIQUE. A PROPOS DE 49 OBSERVATIONSCHEIX SERVONNAT F; AUBOYER C; BONNAFOUS N et al.1973; SEM. HOP.; FR.; DA. 1973; VOL. 49; NO 2; PP. 143-148; ABS. ANGL. ESP. ALLEM.Serial Issue

ERFAHRUNGEN IN DER BEHANDLUNG DER DERMATOMYOSITIS MIT IMMUNOSUPPRESIVA = ESSAIS DES IMMUNOSUPPRESSEURS DANS LE TRAITEMENT DE LA DERMATOMYOSITESTOEGMANN W.1972; PAEDIATR. U. PAEDOL.; OESTERR.; DA. 1972; VOL. 7; NO 3; PP. 305-310; ABS. ANGL.; BIBL. 15REF.Serial Issue

  • Page / 273